Basel, Switzerland (ots/PRNewswire) - Avastin (bevacizumab) remains the only biologic to provide overall survival (OS) benefit when used as first-line treatment in combination with chemotherapy for patients with K-Ras wild type metastatic colorectal cancer (mCRC). Avastin's strong position was confirmed ...
Collegeville, Pennsylvania (ots/PRNewswire) - - First African Nation Plans to Phase in Routine Vaccination Program Against Pneumococcal Disease for Infants and Young Children - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that South Africa has initiated an immunization program against pneumococcal disease with PREVENAR(R) ...
Basel, Switzerland (ots/PRNewswire) - - Final Analysis of Study Confirms Benefit of Avastin(R) for Patients With Lung Cancer BASEL, Switzerland, September 15 /PRNewswire/ -- The final analysis of the Avastin in lung study (AVAiL) in patients with advanced lung cancer has shown that not only did the drug significantly slow down the disease progression, it ...
Southampton, England (ots/PRNewswire) - - Guard channel feature and low voltage operation makes device ideal for portable products Atmel(C) Corporation (Nasdaq: ATML) announced today the AT42QT1060, a touch control chip that integrates 6 channels of touch sensing with the ability to drive up to 7 low ...
Geneva (ots/PRNewswire) - - Study Highlights Underlying Reasons for why Patients are Missing Their Supplementation GENEVA, September 15 /PRNewswire/ -- New research published today at the annual meeting of the American Society for Bone and Mineral Research (ASBMR), Montréal, Canada, reveals that less ...
Stockholm (ots/PRNewswire) - - Patients Live Longer After Treatment With Capecitabine Chemotherapy Combinations Compared With Standard IV 5-FU/FA - For Non-US and Non-UK Media Only Pooled results of two phase III trials have shown that stomach and oesophageal cancer patients treated with oral chemotherapy Xeloda (capecitabine) lived approximately one ...
Basel, Switzerland (ots/PRNewswire) - - Avastin Shows Unprecedented Patient Benefits Regardless of K-Ras Status, Age and Chemotherapy Choice Avastin's (bevacizumab) essential role in the treatment of patients with metastatic colorectal cancer (mCRC), the world's second most common cancer, was ...
Edmonton, Canada (ots/PRNewswire) - MatrikonOPC(TM), the world's leading OPC connectivity provider, will be hosting the only European OPC User Group on October 22, 2008 in Barcelona Spain. The MatrikonOPC User Group will teach attendees how to optimize, implement and integrate OPC Solutions that will automate ...
London (ots/PRNewswire) - - Geophysicists Enjoy Faster Results and Improved IT Center Manageability Panasas, Inc., the global leader in parallel storage solutions, today announced that, through the deployment of a Panasas AS3000 parallel storage solution, Geofizyka Krakow is completing seismic processing ...
Boehringer Ingelheim Animal Health
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Healthcare Media - Global QUEST Study Reveals Dogs With Congestive Heart Failure Have Significantly Improved Survival Outcomes With Vetmedin(R) (pimobendan) Veterinarians and dog owners are today welcoming new research that delivers the promise of an extended happy life together for millions of dog ...
Paris (ots/PRNewswire) - - Abstracts 186 and 1003 Sanofi-aventis announced today that results from two studies, GINGER and LACE, presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD) demonstrated that a basal-bolus insulin regimen with LANTUS(R) (insulin ...
Paris (ots/PRNewswire) - - Abstracts 185 and 1112 Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of Diabetes (EASD) 44th Annual Meeting demonstrating that the "basal plus" insulin strategy ...
LONDON and CAMBRIDGE, England and PHILADELPHIA and HEIDELBERG, Germany, September 10 (ots/PRNewswire) -- - Kinobeads(TM) Technology to Identify a New Generation of Drug Candidates for Inflammatory Diseases Cellzome Inc. and GlaxoSmithKline (LSE & NYSE: GSK) announce the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases. ...
That's Nice LLC; DSM Pharmaceutical Products
Parsippany, New Jersey (ots/PRNewswire) - DSM Pharmaceutical Products (DPP) announced today the appointment of That's Nice LLC as agency of record for marketing services. This relationship, in effect since June 2008, covers services for this DSM business group and its three business units: DSM Pharma ...
Basel, Switzerland (ots/PRNewswire) - - 100+ Abstracts on Roche Medicines Feature at This Congress More than 100 Roche abstracts have been accepted for the biggest cancer congress in Europe, the European Society for Medical Oncology (ESMO), which opens in Stockholm on Friday (12th September). The Roche abstracts include the latest data on Avastin ...
London (ots/PRNewswire) - The 13 members of the Organization of the Petroleum Exporting Countries (OPEC) pumped an average 32.81 million barrels per day (b/d) of crude oil in August, a Platts survey of OPEC and oil industry officials showed September 9. This is 40,000 b/d higher than the July production of 32.77 million b/d. Excluding Iraq, the 12 members ...
Heilbronn, Germany (ots/PRNewswire) - Atmel(R) (Nasdaq: ATML) announced today a significant enhancement to the ATA2270-EK1 125-kHz RFID demo kit. This kit, which enables the evaluation and prototyping of Atmel's wide portfolio of LF IDIC(R)s, has been upgraded to include a PC-based GUI application to ...
Bristol-Myers Squibb and AstraZeneca
Rome (ots/PRNewswire) - - FOR EUROPEAN MEDICAL MEDIA ONLY - New Data Presented for the First Time at EASD 2008 - Saxagliptin With Metformin as Initial Combination Therapy Lowered A1C - Improvements Demonstrated Across Key Measures of Glucose Control Studied in Treatment-Naïve People With Type 2 ...
Bristol-Myers Squibb and AstraZeneca
Rome (ots/PRNewswire) - - FOR EUROPEAN MEDICAL MEDIA ONLY - New Data Presented for the First Time at EASD 2008 - Saxagliptin With Metformin as Initial Combination Therapy Lowered A1C - Improvements Demonstrated Across Key Measures of Glucose Control Studied in Treatment-Naïve People With Type 2 ...
Rome (ots/PRNewswire) - - Exciting New Data From the FIELD Study Show Additional Microvascular-Associated Benefits of Fenofibrate - The First Time in a Large-Scale Prospective Study That any Lipid-Modifying Therapy has Been Shown to Significantly Reduce the Risk of Lower-Limb Amputation in Patients With Type 2 Diabetes Fenofibrate treatment in people ...
Rousset, France (ots/PRNewswire) - - AT73C224 Sources 3V to 5V Supplies, Provides Four Regulated Power Supply Channels, Integrates Real Time Clock and Two Wire Interface Atmel(R) Corporation (Nasdaq: ATML) announced today the release of its AT73C224 Analog Companion Power Management Unit designed for a wide range of applications based on 32-bit MCUs. The ...
Paris (ots/PRNewswire) - - The THIN, ROLE and LIVE-DE Studies Used Medical Databases or Medical Records to Compare the Benefits of Different Insulin Treatments in Thousands of People Living With Type 2 Diabetes - Abstracts 1000, 1001 and 1004 Sanofi-aventis, a world leader in diabetes care, announced ...
Rousset, France (ots/PRNewswire) - - Institute of Embedded Systems, Zurich University of Applied Sciences, Personalizes CAP for UWB Applications Atmel(R) Corporation (Nasdaq: ATML) and the Institute of Embedded Systems (InES), Zurich University of Applied Sciences, announced today the availability of an Ultra Wideband (UWB) transceiver that InES has ...
Abbott Park, Illinois (ots/PRNewswire) - - Abbott Only U.S.-based Fortune 100 Health Care Manufacturer to Be Listed on Both North America and World Indexes Abbott (NYSE: ABT), the global health care company, announced today that it was recognized on the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index for the fourth ...
Maidenhead, England (ots/PRNewswire) - - Prevenar Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Worldwide MAIDENHEAD, England, September 4 /PRNewswire/ -- Wyeth today announced that Cyprus and the Republic of Ireland have initiated national ...
London (ots/PRNewswire) - Doosan Babcock jointly with Doosan Heavy Industries of Korea have announced a Global Technology Licensing Agreement with a leading Canadian CO2 management technology company, HTC Purenergy Inc. ("HTC"). In conjunction with the Licensing Agreement, Doosan Babcock and Doosan Heavy ...
Calgary, Canada (ots/PRNewswire) - - Provides Shareholders With an Update on Strategic Review Activities On behalf of Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) the Board of Directors, due to the recent advancement of various discussions with third parties, feel it is prudent to update the market as to activities surrounding a previously announced strategic review process of January 25, 2007. ...
General Nutrition Centers, Inc.
Pittsburgh (ots/PRNewswire) - General Nutrition Centers, Inc., the largest global specialty retailer of nutritional supplements, today announced another step in its continuing expansion in Europe through an exclusive distribution agreement for online sales of GNC's private label products, its first in Europe, ...
Munich, Germany (ots/PRNewswire) - - In spite of the success of therapies targeting LDL in lowering cardiovascular risk, a residual risk still remains Cardiologists in Europe agree that reducing LDL-cholesterol (LDL-C or "bad" cholesterol) levels is the most important factor in treating dyslipidemia (abnormal blood lipids) and reducing the risk of a ...
Calgary, Canada (ots/PRNewswire) - - Multiple Presentations Included Resverlogix Data - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce that Dr. Norman Wong presented key clinical data pertaining to its lead compound, RVX-208, at the European Society Cardiology (ESC) 2008 Congress in Munich. The presentation titled "RVX-208 a novel small ...